Valuation: Jamjoom Pharmaceuticals Factory Company

Market Cap 10.1B 2.69B 2.35B 2.18B 2B 3.77B 259B 3.86B 26.01B 10.22B 127B 9.88B 437B P/E 2026 *
19.4x
P/E 2027 * -
Enterprise Value 9.78B 2.61B 2.28B 2.11B 1.94B 3.65B 251B 3.74B 25.19B 9.89B 123B 9.57B 423B EV / Sales 2026 *
6.05x
EV / Sales 2027 * 5.18x
Free-Float
38.61%
Yield 2026 *
3.1%
Yield 2027 * 3.45%

Last Transcript: Jamjoom Pharmaceuticals Factory Company

1 day-1.77%
1 week-2.04%
Current month-6.90%
1 month-11.80%
3 months-7.32%
6 months+1.41%
Current year+1.41%
1 week 144
Extreme 144
148.9
1 month 144
Extreme 144
163.3
Current year 125
Extreme 125
163.7
1 year 125
Extreme 125
180.1
3 years 100.2
Extreme 100.2
202.4
5 years 66
Extreme 66
202.4
10 years 66
Extreme 66
202.4
Manager TitleAgeSince
Chief Executive Officer 62 2021-05-14
Director of Finance/CFO 62 2013-01-12
Chief Operating Officer 31 2021-08-31
Director TitleAgeSince
Director/Board Member - 2022-06-18
Chairman 66 2022-06-18
Director/Board Member 41 2022-06-18
Change 5-day change 1-year change 3-year change Capi.($)
-1.77%-2.04%-18.20%+13.62% 2.74B
-0.90%-0.15%+14.11%+81.10% 48.15B
-0.23%-1.65%+67.15%+112.03% 35.59B
-0.76%-1.44%-4.29%+37.63% 11.9B
-0.88%-0.62%+17.31%+89.97% 11.85B
+0.19%+2.87%+34.92%+139.73% 9.31B
+3.37%-0.10%+51.64%-3.75% 7.02B
-0.75%-0.91%+17.45%+37.70% 6.91B
-2.25%-2.08%+0.45%+209.99% 6.55B
-9.93%+0.35%-31.51%+16.58% 6.13B
Average -1.39%+0.03%+14.90%+73.46% 14.61B
Weighted average by Cap. -0.90%-0.42%+25.94%+85.23%

Financials

2026 *2027 *
Net sales 1.62B 431M 377M 348M 320M 604M 41.45B 617M 4.16B 1.64B 20.3B 1.58B 69.97B 1.87B 498M 436M 403M 371M 698M 47.97B 714M 4.82B 1.89B 23.49B 1.83B 80.96B
Net income 521M 139M 121M 112M 103M 195M 13.36B 199M 1.34B 527M 6.54B 510M 22.54B -
Net Debt -317M -84.42M -73.89M -68.26M -62.8M -118M -8.13B -121M -816M -321M -3.98B -310M -13.72B -404M -108M -94.17M -86.99M -80.03M -151M -10.36B -154M -1.04B -409M -5.07B -395M -17.48B
Logo Jamjoom Pharmaceuticals Factory Company
Jamjoom Pharmaceuticals Factory Company SJSC is a Saudi Arabia-based pharmaceutical company, which is primarily focused on developing, manufacturing, and distributing generic pharmaceuticals, cosmetics, and consumer healthcare products. It produces human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhoea, vomiting, and ulcer and acidity, among others. It operates in two segments: The Pharmaceutical products that represents medicines or drugs for the prevention and treatment of diseases, and protection of public health; and The Consumer health products that represents products used to support personal well-being, maintain health, or address specific health-related needs. The Company’s subsidiaries include Al Jamjoom Pharma for Pharmaceutical Industries and Jamjoom Pharmaceutical Industry and Commerce Company Limited and the Company also operates approximately 8 branches.
Employees
-
Date Price Change Volume
26-07-19 SAR 144.30 -1.77% 17,452
26-07-16 SAR 146.90 -1.34% 18,428
26-07-15 SAR 148.90 +2.69% 46,390
26-07-14 SAR 145.00 -1.09% 13,093
26-07-13 SAR 146.60 -0.81% 92,857
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
144.30SAR
Average target price
164.24SAR
Spread / Average Target
+13.82%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4015 Stock